Clinical Trial Update: Cytoreduction Followed by Normothermic Versus Hyperthermic Intraperitoneal Intraoperative Chemoperfusion (HIPEC): a Study in Peritoneal Carcinomatosis [Phase 2]

View source ↗

Summary

Phase 2 trial comparing cytoreduction followed by normothermic vs hyperthermic intraperitoneal chemoperfusion (HIPEC) in peritoneal carcinomatosis has completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peritoneal Carcinomatosis

Snippet

Sponsor: University Hospital, Ghent | Conditions: Peritoneal Carcinomatosis | Phase 2 | Status: COMPLETED